Molecular Medicine
Cure8 research brief
TGF-β1 signaling in Crohn’s disease
Research and clinical trials
Microbiome
Clinical study
Clinicians
Researchers
Adult patients
Crohn's disease
Inflammatory bowel disease
Why This Matters
TGF-β1 is a central regulator implicated in inflammation control, development of fibrosis, and possible cancer progression in Crohn’s disease; advances in this area could inform future treatments or biomarker development.
Who Should Pay Attention
Clinicians and researchers studying immune pathways, fibrosis, or cancer risk in IBD; adult patients interested in the biology of Crohn’s disease and emerging therapeutic targets.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthMetadata only
What To Know
This is a scholarly review article that compiles published findings on TGF-β1 and its downstream signaling (including Smad-dependent and non‑Smad pathways) in the context of CD.
The authors highlight roles for TGF-β1 in shaping T-cell balance (Treg vs Th17), in promoting fibrosis through epithelial/endothelial-to-mesenchymal transitions, and in interacting with the intestinal microbiome and tumor microenvironment.
The review discusses Smad7 overexpression in inflamed mucosa and how disrupted TGF-β1 signaling may reduce immune tolerance, contributing to ongoing inflammation and barrier dysfunction.
It also outlines the complex, stage-dependent relationship between TGF-β1 and colitis-associated cancer, where TGF-β1 may suppress early tumor formation but promote progression later.
The paper surveys potential therapeutic strategies that target TGF-β1 pathways, as well as mechanistic links to microbiota and fibrosis, but it does not present new clinical trial results.
Keep In Mind
This item is a review article published in Molecular Medicine (open access). It synthesizes existing studies rather than reporting new trial results. Findings and proposed therapeutic ideas are drawn from the literature summarized by the authors.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationMolecular Medicine
PublisherSpringer Science and Business Media LLC
AuthorsYanji Wang, Jun Shen
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 17, 2026, 12:00 AM
Content availableMetadata only
Funding disclosed by the source: the Most Important Discipline, Baoshan Medical Key Discipline and Characteristic Brand Construction Project, award BSZK-2023-Z06; 2022 Baoshan Medical and Health Project, award 2023-E-13; Cultivation Funding for Clinical Scientific Research Innovation, Renji Hospital, School of Medicine, Shanghai Jiaotong University, award RJPY-LX-004
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Psoriasis Linked To Gut Infection And Multiplied Danger Of Crohn's Sickness - India Herald
The article connects psoriasis and Crohn's disease through shared immune pathways and the gut-skin axis, which may matter because people with one condition could have signs or risks related to the other. It emphasizes...
Gut microbiome: a key driver and therapeutic target of intestinal fibrosis in Crohn's disease.
Intestinal fibrosis causes strictures that often need surgery and has few effective medical treatments; linking the microbiome to fibrogenesis suggests new prevention or treatment strategies that could reduce surgery...
Crohn's and the Environment: Evidence-Based Insights - Medscape
Environmental pollutants are increasingly linked to Crohn's disease risk, especially when exposures occur in early life. Understanding these links may help explain rising IBD rates and guide future prevention research.